Insider · CIK 0001601360
Halley E Gilbert
Files at CTMX (CytomX Therapeutics, Inc.), PCVX (Vaxcyte, Inc.), ARQT (Arcutis Biotherapeutics, Inc.). First filing Nov 21, 2025, latest Nov 21, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ARQT: Arcutis Biotherapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 42Moderate | Arcutis Biotherapeutics, Inc. | $455k 16,532 shares | -43% | +170% from low-2% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 20, 2025 | ARQT Arcutis Biotherapeutics, Inc. | MOption exercise Common Stock | +12,220 | $7.51 | $92k | 38,655 | Nov 21, 2025 |
| Nov 20, 2025 | ARQT Arcutis Biotherapeutics, Inc. | SOpen-market sale Common Stock | -16,532 | $27.55 | $455k | 22,123 | Nov 21, 2025 |
| Nov 20, 2025 | ARQT Arcutis Biotherapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative | -12,220 | $0.00 | $0 | 0 | Nov 21, 2025 |
| Jun 12, 2025 | ARQT Arcutis Biotherapeutics, Inc. | AGrant or award Common Stock | +7,609 | $0.00 | $0 | 26,435 | Jun 16, 2025 |
| Jun 12, 2025 | PCVX Vaxcyte, Inc. | AGrant or award Common Stock | +3,041 | $0.00 | $0 | 10,216 | Jun 16, 2025 |
| Jun 12, 2025 | ARQT Arcutis Biotherapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +20,568 | $0.00 | $0 | 20,568 | Jun 16, 2025 |
| Jun 12, 2025 | PCVX Vaxcyte, Inc. | AGrant or award Stock Option (right to buy)derivative | +15,372 | $0.00 | $0 | 15,372 | Jun 16, 2025 |
| Jun 11, 2025 | CTMX CytomX Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +38,000 | $0.00 | $0 | 38,000 | Jun 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.